Disease | hepatitis b |
Phenotype | C1261473|sarcoma |
Sentences | 1 |
PubMedID- 22048500 | In a study performed on more homogenous types of cancers, it was determined that the decrease in vaccine-mediated antibody titers for hepatitis b was highest in patients with sarcoma and that the posttreatment antibody titers decreased below the protection level in 64% of the patients.10 in the present study, we investigated antibody titers in a heterogeneous group of patients, including those with leukemia, lymphoma, and solid tumors. |
Page: 1